PlainRecalls
FDA Drug Low Class III Terminated

Levofloxacin Injection in 5% Dextrose, 5 mg/mL, packaged in a) 50 mL (NDC 36000-046-24), b) 100 mL (NDC 36000-047-24), c) 150 mL (NDC 36000-048-24) Container bags, Rx only, Manufactured for: Claris Lifesciences Inc., North Brunswick, NJ 08902; By: Claris Injectables Ltd., Gujarat, India.

Reported: October 3, 2018 Initiated: September 25, 2018 #D-1215-2018

Product Description

Levofloxacin Injection in 5% Dextrose, 5 mg/mL, packaged in a) 50 mL (NDC 36000-046-24), b) 100 mL (NDC 36000-047-24), c) 150 mL (NDC 36000-048-24) Container bags, Rx only, Manufactured for: Claris Lifesciences Inc., North Brunswick, NJ 08902; By: Claris Injectables Ltd., Gujarat, India.

Reason for Recall

Superpotent Drug: High out of specification results for levofloxacin resulting in increased concentration of solution.

Details

Units Affected
523,896 bags
Distribution
Nationwide USA and Puerto Rico
Location
Deerfield, IL

Frequently Asked Questions

What product was recalled?
Levofloxacin Injection in 5% Dextrose, 5 mg/mL, packaged in a) 50 mL (NDC 36000-046-24), b) 100 mL (NDC 36000-047-24), c) 150 mL (NDC 36000-048-24) Container bags, Rx only, Manufactured for: Claris Lifesciences Inc., North Brunswick, NJ 08902; By: Claris Injectables Ltd., Gujarat, India.. Recalled by Baxter Healthcare Corporation. Units affected: 523,896 bags.
Why was this product recalled?
Superpotent Drug: High out of specification results for levofloxacin resulting in increased concentration of solution.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 3, 2018. Severity: Low. Recall number: D-1215-2018.